Harry A. Drabkin

University of Colorado Health · US

Area of research

Pulmonary and Respiratory Medicine · Molecular Biology

Research interest

Research interests include Renal cell carcinoma treatment, Angiogenesis and VEGF in Cancer, Axon Guidance and Neuronal Signaling, and Cancer Genomics and Diagnostics.

h-index

citations

13,879

works

261

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma

Clinical Cancer Research 2015cited by 38position: middledoi

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Investigational New Drugs 2013cited by 408position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Noah M. Hahn · University Hospital Regensburg1 papers (2015–2015)Christopher J. Sweeney · Harvard University1 papers (2015–2015)— · 1 papers (2015–2015)Damian A. Laber · University of South Florida1 papers (2013–2013)— · 1 papers (2015–2015)Shailender Bhatia · University of Washington1 papers (2015–2015)Ralph J. Hauke · Nebraska Cancer Specialists1 papers (2015–2015)Ravindran Kanesvaran · SingHealth1 papers (2015–2015)Eliezer M. Van Allen · Harvard University1 papers (2013–2013)Sumanta K. Pal · City of Hope1 papers (2015–2015)Jonathan E. Rosenberg · New York Oncology Hematology1 papers (2013–2013)Robert A. Figlin · Molecular Oncology (United States)1 papers (2013–2013)Richard C. Lauer · University of New Mexico1 papers (2015–2015)Guru Sonpavde · AdventHealth Orlando1 papers (2015–2015)Toni K. Choueiri · Harvard University1 papers (2013–2013)Levi A. Garraway · Cancer Research Center1 papers (2013–2013)José Iglesias · University of Lausanne1 papers (2015–2015)John Sarantopoulos · Cancer Clinic1 papers (2015–2015)— · 1 papers (2015–2015)Andrea Harzstark · Kaiser Permanente1 papers (2013–2013)